FBS drug

Aliases

10% FBS (HyClone), Fetal Bovine Serum, fetal bovine serum

External links

DrugBank · PubChem

No related entities found.

Mentioned in (40)

Papers in which this entity is mentioned.

• Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
• 3D spatial organization of heterogeneous nkx2.5+ progenitors in the zebrafish heart field pre-patterns cardiovascular development. (2025)
• Connectome-seq: High-throughput Mapping of Neuronal Connectivity at Single-Synapse Resolution via Barcode Sequencing. (2025)
• Multigenerational cell tracking of DNA replication and heritable DNA damage. (2025)
• Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
• Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
• Single cell and spatial alternative splicing analysis with Nanopore long read sequencing. (2025)
• Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition. (2025)
• MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
• Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
• ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data. (2023)
• Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
• Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. (2022)
• Single-cell genomic variation induced by mutational processes in cancer. (2022)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X. (2020)
• AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications. (2020)
• Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. (2019)
• Designing combination therapies with modeling chaperoned machine learning. (2019)
• RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types. (2019)
• Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
• Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. (2019)
• Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
• Nanopore sequencing and assembly of a human genome with ultra-long reads. (2018)
• EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. (2018)
• Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
• Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. (2017)
• Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
• PGBD5 promotes site-specific oncogenic mutations in human tumors. (2017)
• Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. (2017)
• Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. (2016)
• Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
• Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells. (2016)
• The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS. (2015)
• A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
• CONSERTING: integrating copy-number analysis with structural-variation detection. (2015)
• Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. (2015)
• Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.